Form 4 filed by Kumar Neil
Kumar Neil filed this Form 4 on BBIO (BridgeBio Pharma, Inc.) with 9 transaction rows and 3 holding rows, accepted by EDGAR 2026-11-19 00:36:08 UTC.
- Accession
- 0001743881-26-000039
- Filer
- CIK 1742485
- Filed
- 2026-11-18
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: BBIO · BridgeBio Pharma, Inc. (CIK 1743881)
- Kumar Neil director, officer (Chief Executive Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-16 | M exercised | +33,544 | 276,871 | D | |
| Common Stock | 2026-11-16 | M exercised | +19,599 | 296,470 | D | |
| Common Stock | 2026-11-16 | M exercised | +11,554 | 308,024 | D | |
| Common Stock | 2026-11-16 | M exercised | +6,519 | 314,543 | D | |
| Common Stock | 2026-11-16 | F withheld for tax | -36,236 | $77.36 | 278,307 | D |
| Common Stock holding | 495,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | ||||
| Common Stock holding | 750,000 | I By NK 2026 GRAT | ||||
| Common Stock holding | 3,568,447 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | ||||
| Restricted Stock Units derivative | 2026-11-16 | M exercised | -33,544 | $0 | 33,544 | D |
| Restricted Stock Units derivative | 2026-11-16 | M exercised | -19,599 | $0 | 97,997 | D |
| Restricted Stock Units derivative | 2026-11-16 | M exercised | -11,554 | $0 | 103,984 | D |
| Restricted Stock Units derivative | 2026-11-16 | M exercised | -6,519 | $0 | 84,755 | D |